Genmab - M&A Summary and Business Overview

Life ScienceCompany

Genmab M&A Summary

Genmab has acquired 1 company, including 1 in the last 5 years.

Genmab’s largest acquisition to date was in 2024, when it acquired ProfoundBio for $1.8B. Genmab has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Genmab Business Overview

Where is Genmab headquartered?

Genmab is headquartered in Valby, Denmark.

What is Genmab’s revenue?

Genmab disclosed revenue of 16,474M DKK for 2023 and 14,505M DKK for 2022.

What sector is Genmab in?

Genmab is a life science company.

When was Genmab founded?

Genmab was founded in 1999.

M&A Summary

M&A Total Activity1
- M&A Buy Activity1
Total Sectors Invested 1
Total Countries Invested 1
M&A Advisors 4

Genmab

Genmab A/S

Carl Jacobsens Vej 30,
Valby, 2500
Denmark,
+45 7020 2728
www.genmab.com

Genmab is an international biotechnology company using its antibody technology platform to offer bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function-enhanced antibodies, and antibody-drug conjugates. Genmab was formed in 1999 and is headquartered in Copenhagen, Denmark.

M&A Summary

Buy vs Sell

Year		≤ '19	'20	'21	'22	'23	'24	T
Buy (0.2/yr)	#	-	-	-	-	-	1	1
Buy (0.2/yr)	vol						$1.8B	$1.8B
Sell (0.0/yr)	#	-	-	-	-	-	-	0
								1

Most Recent M&A

Company	Date	Value	Type
ProfoundBio, Inc.	2024-04-03	1.8B USD	Add-on Acquisition
Seattle, Washington · www.profoundbio.com
View All >>

M&A by Sector

Sector		Buy #	Value	Sell #	Value
Life Science		1 (100%)	1.8B (100%)	-	-
Total		1	$1.8B	-	-

By Geo

State/Country		Buy	Value	Sell	Value
United States		1	1.8B	-	-
	Washington	1	1.8B	-	-
Total		1	$1.8B	-	-

Top M&A Advisors

Financial	Deals
Goldman Sachs	1

Legal	Deals
Simmons & Simmons	1
Kromann Reumert	1
Shearman & Sterling	1

Deal Values

buy	#	Total
> $1B	1	$1.8B
TOTAL		$1.8B
Largest	ProfoundBio, Inc. $1.8B (2024-04-03)

Company Summary

SECTOR

Life Science

Revenue

16,474 14%	2023
14,505 73%	2022
8,417 17%	2021
10,111	2020
(millions of DKK)	Show More Show Less

Established

1999

Public

NASDAQ: GMAB

Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

Unlimited Searches
Unlimited Profile Views
Build and Export Lists of

PE Backed Companies
Direct Investors & Acquirers
Advisors
Deals
& More

1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

Stay informed on events in your industry
M&A research that takes seconds (not all afternoon)
Better understand your customers and prospects
Discover active buyers (or sellers)

Search

4.6K Private Equity Firms
200K M&A Transactions
203K Companies Involved in M&A
(Buyer, Seller, or Target)
3.6K M&A Advisors
(Investment Banks and Law Firms)
81K M&A Contacts
(PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Genmab

Life Science Companies , Denmark Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Denmark Companies

Largest Denmark Companies , Acquisitive Denmark Companies , Recently Acquired Denmark Companies , Recently Sold Denmark Companies , Private Denmark Companies , Public Denmark Companies , Acquired Denmark Companies , PE Backed Denmark Companies

Genmab - M&A Summary and Business Overview

Life ScienceCompany